Integrated Quantitative Investments LLC Takes Position in Encompass Health Corporation $EHC

Integrated Quantitative Investments LLC purchased a new position in shares of Encompass Health Corporation (NYSE:EHC) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 13,555 shares of the company’s stock, valued at approximately $1,662,000.

A number of other institutional investors also recently added to or reduced their stakes in the business. ANB Bank acquired a new position in Encompass Health during the 2nd quarter worth approximately $261,000. Ontario Teachers Pension Plan Board boosted its stake in shares of Encompass Health by 9.8% in the second quarter. Ontario Teachers Pension Plan Board now owns 24,051 shares of the company’s stock valued at $2,949,000 after buying an additional 2,137 shares in the last quarter. Cetera Investment Advisers grew its holdings in Encompass Health by 50.7% during the second quarter. Cetera Investment Advisers now owns 23,856 shares of the company’s stock worth $2,925,000 after acquiring an additional 8,022 shares during the period. Creative Planning raised its position in Encompass Health by 14.9% in the second quarter. Creative Planning now owns 28,328 shares of the company’s stock worth $3,474,000 after acquiring an additional 3,681 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in Encompass Health by 7.5% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 25,898 shares of the company’s stock valued at $3,176,000 after acquiring an additional 1,815 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Down 0.7%

Shares of EHC opened at $113.49 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.99. The stock has a market cap of $11.42 billion, a price-to-earnings ratio of 21.45, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. The firm has a 50 day simple moving average of $122.64 and a 200-day simple moving average of $119.69.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s payout ratio is presently 14.37%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on EHC shares. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Bank of America increased their target price on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. UBS Group lifted their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. KeyCorp upped their price target on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Finally, Zacks Research raised Encompass Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. Three research analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company’s stock. Based on data from MarketBeat.com, Encompass Health has an average rating of “Buy” and an average price target of $142.86.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares of the company’s stock, valued at $2,329,177.14. This trade represents a 5.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.00% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.